Isomorphic Labs nears more than $2 billion funding round
Updated
Updated · Bloomberg · May 8
Isomorphic Labs nears more than $2 billion funding round
10 articles · Updated · Bloomberg · May 8
Thrive Capital is set to lead the financing, with Alphabet also participating, according to people familiar with the matter.
The AI drug-discovery company, spun out of Google DeepMind, is in advanced discussions, though the round has not yet closed.
The deal would follow Isomorphic Labs' first funding round last year, also led by Thrive Capital, underscoring investor appetite for AI-driven biotech.
Is Isomorphic Labs' $2 billion funding a landmark for AI medicine or a bubble set to pop before clinical proof?
Its AI reportedly doubles AlphaFold's power, but with results secret, can it actually deliver cures for patients?